ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
27 hedge funds and large institutions have $13.7M invested in Elevation Oncology in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
5
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$456K |
| 2 |
AC
2
Annandale Capital
Dallas,
Texas
|
$48K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$4K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$1.69K |
| 5 |
5
BlackRock
New York
|
$35.7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $16 | 17 | +17 | New |
|
|
MAM
27
Marquette Asset Management
Minneapolis,
Minnesota
| – | – | -38,951 | Closed |
|
28
Osaic Holdings
Scottsdale,
Arizona
| – | – | -1,100 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -169 | Closed |
|
30
Barclays
London,
United Kingdom
| $0 | 392 | – | – |
|
|
CFGS
31
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|